Table 1.
Conventional (36 subjects) | MIO (32 subjects) | Average difference (95 % CI) | p Value | |
---|---|---|---|---|
Age (years) | 84.7 ± 7.20 | 82.78 ± 7.71 | 1.91 (−1.69 to 5.52) | 0.2938 |
Type of fracture | 1.89 ± 0.67 | 2.00 ± 0.57 | −0.11 (−0.41 to 0.19) | 0.4650 |
Time from hospitalization to surgery (h) | 57.58 ± 28.04 | 56.97 ± 52.76 | 0.61 (−19.53 to 20.76) | 0.9516 |
Anticoagulant/antiplateleta | 0.47 ± 0.51 | 0.37 ± 0.49 | 0.09 (−0.14 to 0.34) | 0.4260 |
Number of comorbidities | 2.33 ± 1.35 | 2.56 ± 1.24 | −0.23 (−0.86 to 0.40) | 0.4713 |
There are no significant differences between the two groups (Student t test)
aOne patient used oral anticoagulants (coumarin) and 12 used oral antiplatelet drugs in the MIO group. Two patients used oral anticoagulants and 17 used oral antiplatelet drugs in the DHS conv group